Medical/Pharmaceuticals
Senhwa's Silmitasertib, COVID-19 Drug Candidate, Receives Positive Interim Review from Data Monitoring Committee to Proceed
TAIPEI and SAN DIEGO, Aug. 31, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced that its oral new drug, Silmitasertib, had received a positive feedbac...
2021-08-31 19:00
2110
Alithea Genomics Launches BRB-Seq Kits for High-Throughput RNA-Seq of Tissue, Cells and Blood Samples
LAUSANNE, Switzerland, Aug. 31, 2021 /PRNewswire/ -- Alithea Genomics, a rapidly growing player in the transcriptomics field, has announced today the launch of its first MERCURIUS BRB-seq kits, which enable high-throughput and cost-efficient RNA-seq library preparation from a wide range of RNA sa...
2021-08-31 19:00
3227
CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services
MONTRÉAL, Aug. 31, 2021 /PRNewswire/ -- CellCarta and Olink Proteomics AB
announced today a strategic collaboration to offerOlink® Target 96 & Target 48
to pharmaceutical and biotech customers, advancing targeted protein biomarker
quantification in clinical studies.
2021-08-31 19:00
3344
Pharmaxis Treatment to Prevent Wound and Burns Scars Clears Phase 1 Trial
* Topical treatment safe and well tolerated in study of healthy volunteers * Full inhibition of lysyl oxidase enzymes achieved in skin with minimal systemic exposure * Collaboration with research team led by Professor Fiona Wood AM planning for trial in patients with established scars to com...
2021-08-31 18:00
2121
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2021
* 13 significant clinical milestones achieved year-to-date, including critical positive data readout events for felzartamab (TJ202/MOR202), lemzoparlimab (TJC4), uliledlimab (TJD5), and plonmarlimab (TJM2) and more milestone achievements are expected before the year-end 2021 * Felzartamab (TJ...
2021-08-31 18:00
3925
Elekta Unity MR-Linac featured in 72 abstracts at European radiation oncology congress
MADRID, August 31, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 72 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac. The research described in the abstracts was conducted at 14 leading cancer centers worldwide, ref...
2021-08-31 14:21
2220
Harbour BioMed Reports 2021 Interim Results
CAMBRIDGE, Mass.and SUZHOU, China and ROTTERDAM, Netherlands, Aug. 31, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, reported its interim...
2021-08-31 13:47
4250
HeartCare Medical Announces 2021 Interim Results
HONG KONG, Aug. 31, 2021 /PRNewswire/ -- Shanghai HeartCare Medical Technology Corporation Limited ("HeartCare Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 6609), a leading player in China's neuro-intervention market, announced its interim results for the si...
2021-08-31 13:11
4139
Digital Health Platform Doctor Anywhere Closes S$88 Million Series C Round to Deepen Southeast Asia Expansion
* The company has experienced a 500 percent growth in the business since the start of 2020. * The investment will significantly bolster DA's market leadership and its mission to transform the regional healthcare landscape through technology. SINGAPORE, Aug. 31, 2021 /PRNewswire/ -- Doctor Any...
2021-08-31 10:00
8910
InnoCare Announces Clearance by U.S. FDA of Clinical Trial of pan-TRK Inhibitor ICP-723
BEIJING, Aug. 30, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biopharmaceutical company, announced today the Investigational New Drug (IND) clearance of its second-generation pan-TRK inhibitor ICP-723 by the US Food and Drug Administration (FDA) for starting phase I cli...
2021-08-31 08:30
3047
Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows
MILAN, Aug. 31, 2021 /PRNewswire/ -- The number of solid organ transplants
performed during the first wave of COVID-19 in 2020 plunged by 31% compared to
the previous year, according to a new global study presented at theEuropean
Society for Organ Transplantation (ESOT) Congress 2021
2021-08-31 07:01
2905
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022
1Q22 Added 19,673 New Subscribers Revenues Up 12.2% YoY to RMB315.2 Million ($48.8 Million) Gross Profit Up 12.6% YoY to RMB267.3 Million ($41.4 Million) Operating Income Up 17.3% YoY to RMB156.6 Million ($24.2 Million) Non-GAAP Operating Income Up 15.5% YoY to RMB168.5 Million ($26.1 Million) Confe...
2021-08-31 04:16
5133
Thrombosis Research Institute (TRI) Shares Six New GARFIELD-AF And RIVER Real-world Data Analyses At ESC Congress 2021
- Four GARFIELD-AF e-posters shine light on managing atrial fibrillation (AF) in patients with clinically challenging conditions and diabetes, as well as on AF trial populations - Two RIVER e-posters provide two-year outcomes data and insights on appropriate dosing and renal function in patients...
2021-08-31 03:56
2865
LifeTech Scientific Corporation Announces 2021 Interim Results
SHENZHEN, China, Aug. 31, 2021 /PRNewswire/ -- LifeTech Scientific Corporation (LifeTech, 01302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 interim results. Compared with...
2021-08-31 03:46
6259
Viva Biotech Announced 2021 Interim Results
Revenue Increased by 419.5% YoY, CRO Business Income Increased by 62.5% YoY, O rderBacklog Recorded a Significant Increase of 72% Financial Highlights for the 6 months ended June 30, 2021: * Revenue amounted to RMB1,026.5 million, representing a year-on-year (YoY) increase of approximately 419...
2021-08-31 01:32
5752
Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix
SEOUL, South Korea, Aug. 30, 2021 /PRNewswire/ -- CancerRop (180400), a company specializing in precision medicine and molecular diagnostics, announced a jump start in the global vaccine hub for COVID-19 mRNA (messenger ribonucleic acid) with Hanmi Science through20 billion won worth of investmen...
2021-08-30 23:00
3831
Everest Medicines Announces Half-Year 2021 Interim Results
SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines
2021-08-30 22:15
5761
Everest Medicines Announces Up to HK$100 million Share Repurchase Program
SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...
2021-08-30 22:03
4916
Approval to Market Sofwave(TM) in South Korea
Key Regulatory Milestone in Company's International Growth Strategy for Unrivaled Ultrasound Technology Treating Fine Lines and Wrinkles YOQNEAM, Israel, Aug. 30, 2021 /PRNewswire/ -- Sofwave Medical LTD, today announced it has received approval from the Korean Ministry of Foods and Drug Safety ...
2021-08-30 20:30
3083
I-Mab Announces Upcoming Participation at September Conferences
SHANGHAI and GAITHERSBURG, Md., Aug. 30, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in Septem...
2021-08-30 20:00
2180
Week's Top Stories
Most Reposted
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
The Philippines Sets a New Standard in Muslim-Friendly Tourism
[Picked up by 286 media titles]
2026-05-26 10:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15ISDN's IDI Dynamics debuts high-speed laser marker for semiconductor assembly and test (OSAT)
[Picked up by 280 media titles]
2026-05-26 08:40
Consistently recognised: Infobip named a Leader in Gartner® Magic Quadrant™ for CPaaS again
[Picked up by 279 media titles]
2026-05-21 16:31
Most Read
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
8224
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
8004
